日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Radiomics and blood biomarkers for predicting efficacy of sintilimab plus lenvatinib in advanced hepatocellular carcinoma

放射组学和血液生物标志物用于预测信迪利单抗联合乐伐替尼治疗晚期肝细胞癌的疗效

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1782008
Cui, Yong; Wang, Lijun; Li, Xiaoting; Wang, Kun; Wang, Hongwei; Bao, Quan; Zhu, Haitao; Gu, Xiaolei; Xing, Qian; Jin, Kemin; Sun, Yingshi; Xing, Baocai
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial

抗PD-L1/CTLA-4双特异性抗体KN046联合乐伐替尼治疗晚期不可切除或转移性肝细胞癌：一项II期临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56537-y
Xu, Da; Wang, Hongwei; Bao, Quan; Jin, Kemin; Liu, Ming; Liu, Wei; Yan, Xiaoluan; Wang, Lijun; Zhang, Yanqiao; Wang, Guangyu; Ma, Yue; Ma, Zhigang; Zhang, Chunhui; Tang, Jiebing; Wang, Sha; Pang, Jiaohui; Xu, Ting; Wang, Kun; Xing, Baocai
PD-L1
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma

长链非编码RNA LINC01532维持氧化还原稳态并加速肝细胞癌对乐伐替尼的耐药性

期刊:Journal of Advanced Research
影响因子:13
doi:10.1016/j.jare.2025.02.035
Hu, Yang; Chen, Muhua; Sun, Shiqi; Zhang, Chunfeng; Xin, Zechang; Sun, Xiaoyan; Wang, Kun; Jin, Kemin; Du, Xiaojuan; Xing, Baocai; Liu, Xiaofeng
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)

关于2022年中国胰腺癌诊疗国家指南（英文版）的评论

期刊:Chinese Journal of Cancer Research
影响因子:6.3
doi:10.21147/j.issn.1000-9604.2022.06.13
Jin, Kemin; Xing, Baocai
胰腺癌
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value

结直肠癌肝转移基因组改变的特征及其预后价值

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.3
doi:10.3389/fcell.2021.760618
Bao, Xuanwen; Wang, Kun; Liu, Ming; Li, Bin; Wang, Hongwei; Jin, Kemin; Yan, Xiaoluan; Zhang, Hangyu; Bao, Quan; Xu, Da; Wang, Lijun; Liu, Wei; Wang, Yanyan; Li, Juan; Liu, Lijuan; Fang, Weijia; Xing, Baocai
肿瘤
肠癌
肿瘤免疫
发表日期：2021
文献求助 收藏

NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.

NAT10 在肝细胞癌中表达上调，并增强突变 p53 的活性

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-017-3570-4
Li Qijiong, Liu Xiaofeng, Jin Kemin, Lu Min, Zhang Chunfeng, Du Xiaojuan, Xing Baocai
细胞生物学
P53
发表日期：2017
文献求助 收藏